Y@I|(7816:*P?:?,8>]KB>.I5^V)UB
SYSTEM PROCESSING...
Y@I|(7816:*P?:?,8>]KB>.I5^V)UB
SYSTEM PROCESSING...
Posted: 2025-05-30 10:55:45 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-05-30 10:56:23 UTC
Verified By
Rollup News
Several neurology drugs have received expedited FDA approvals, sometimes against advisory panel advice, prompting calls for closer scrutiny of FDA-industry interactions.
Expedited FDA approvals for neurology drugs
Potential conflicts with advisory panel recommendations
Need for improved communication between FDA and industry
Conflicting recommendations between FDA and advisory panels
Potential influence of industry on FDA decisions
Ensuring drug safety and efficacy with expedited approvals